Revance Therapeutics shares owned by Stifel Financial
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Stifel Financial
from 13F filings
Historical chart of Stifel Financial investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Stifel Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Stifel Financial
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $167k | 19k | 8.79 |
| 2023-09-30 | $172k | 15k | 11.47 |
| 2023-06-30 | $361k | 14k | 25.31 |
| 2023-03-31 | $480k | 15k | 32.21 |
| 2022-12-31 | $313k | 17k | 18.46 |
| 2022-09-30 | $586k | 22k | 27.00 |
| 2022-06-30 | $232k | 17k | 13.83 |
| 2021-09-30 | $442k | 16k | 27.88 |
| 2021-06-30 | $362k | 12k | 29.68 |
| 2021-03-31 | $338k | 12k | 27.94 |
| 2020-12-31 | $393k | 14k | 28.35 |
| 2020-09-30 | $276k | 11k | 25.12 |
| 2020-06-30 | $335k | 14k | 24.40 |
| 2020-03-31 | $204k | 14k | 14.99 |
| 2019-12-31 | $321k | 20k | 16.47 |
| 2019-09-30 | $311k | 23k | 13.51 |
| 2019-06-30 | $287k | 22k | 13.18 |
| 2019-03-31 | $422k | 28k | 15.11 |